Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Certain glycine derivatives as factor Xa inhibitors for use in the treatment of thrombotic disorders

Certain glycine derivatives as factor Xa inhibitors for use in the treatment of thrombotic disorders

US Patent 7078415 · Granted Jul 18, 2006

Estimated economic value: $239,286,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

KRas inhibitors2025
Selective estrogen receptor degraders2024
Selective estrogen receptor degraders2024
Selective estrogen receptor degraders2024
Benzolactam compounds as protein kinase inhibitors2024
Selective estrogen receptor degraders2023
Selective estrogen receptor degraders2023
Imidazolidine compounds2021
Selective estrogen receptor degraders2021
Selective estrogen receptor degraders2021
Benzolactam compounds as protein kinase inhibitors2021
Substituted pyrazines as ATR kinase inhibitors2021